Document is current
Any future updates will be listed below
-
Authors
Grotemeyer, Alexander https://orcid.org/0000-0002-9185-257X
Petschner, Tobias https://orcid.org/0009-0001-2231-5500
Peach, Robert https://orcid.org/0000-0002-8738-5825
Hoehl, Dirk https://orcid.org/0009-0003-1643-9640
Knauer, Torsten https://orcid.org/0009-0005-0703-4005
Thomas, Uwe
Endres, Heinz
Blum, Robert https://orcid.org/0000-0002-5270-3854
Sendtner, Michael https://orcid.org/0000-0002-4737-2974
Volkmann, Jens https://orcid.org/0000-0002-9570-593X
Ip, Chi Wang https://orcid.org/0000-0003-0484-385X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (424778381-TRR 295 A01, A02, A05, A06)
Deutsche Forschungsgemeinschaft (424778381-TRR 295 A05)
Deutsche Forschungsgemeinschaft (424778381-TRR 295 A01 A06)
Stiftung VERUM
- License Information
-
More Information
Article History
Received: 1 February 2024
Accepted: 29 July 2024
First Online: 14 August 2024
Competing interests
: A.G., T.P., R.P., H.E., R.B., M.S., J.V., and C.W.I. declare that there are no conflicts of interest. D.H., T.K., and U.T. are directly related to Thomas Recording GmbH. The implantable microstimulation system used in this article was manufactured by Thomas RECORDING GmbH, Germany, as a prototype for testing. After the here reported tests had been finished, the product was commercialized by the private industry company Thomas RECORDING GmbH. The author Uwe Thomas (CEO) is owner-manager; the author Dirk Hoehl is technical director and the author Torsten Knauer is head of the electrode department of Thomas RECORDING GmbH. They all may financially benefit from this circumstance if the company is successful in marketing its products that are related to this research.
